Introduction
Wilson's disease, first described in 1912,1 is an diagnosis in patients where the clinical features suggest Wilson's disease. Overlap of caeruloplasmin autosomal recessive disorder of biliary copper excretion resulting in copper toxicity, initially to liver and concentrations in normal individuals with heterozygotes and homozygotes for Wilson's disease was subsequently to the brain and other systems.2 It has a worldwide prevalence of 1 in 35 000 live births noted by Walshe in his Hudson memorial lecture. 5 Caeruloplasmin, a single-chain glycoprotein and the prevalence of the heterozygote carrier state is slightly higher than 15100.3 Although there are a (132 kDa) is synthesized in the liver and transports copper from the liver to other body tissues. Its copper number of clinical presentations arising from excess copper deposition in various organs, some, such as content confers specific copper oxidase activity. 6 Previous work in our laboratory suggests that caeruloKayser-Fleischer (K-F) rings in the cornea in association with reduced or absent plasma caeruloplasmin plasmin may also be a major form in which copper is transported in bile for excretion, thus linking and increased hepatic copper concentration, are pathognomonic. 4 The pathogenesis of this disease is caeruloplasmin to the Wilson's disease gene defect. 7 Furthermore, we have shown that plasma caeruloattributed to the increasing copper accumulation and not to the alteration in caeruloplasmin. 4 However, plasmin exists predominantly in two molecular isoforms, a 132 kDa (plasma) and a 125 kDa (biliary) not all Wilson's disease patients have the same characteristics: plasma caeruloplasmin levels may species.8 To date, a reliable non-invasive confirmatory diarange from the undetectable to the low-normal range. 4 This may make it difficult to confirm the gnostic test for Wilson's disease has been to measure urine copper excretion over 24 h and uptake of and 0.3 ml 0.25% p-phenylenediamine (PPD) which had been pre-equilibrated at 37°C for 5 min in radiocopper (Cu64 and Cu67). 
SDS-PAGE and Western blotting
disease is summarized in Table 2 and Figure 2 . The Serum samples (200 mg protein) from normal control 125 kDa species in serum is very much less in subjects (healthy volunteers with normal liver funcWilson's disease compared with all other categories, tion tests), patients with hepatological or neurological particularly those subjects with hypocaeruloplasclinical features mimicking Wilson's disease, patients minaemia and with those patients' sera with hepatowhere the total caeruloplasmin concentrations were logical or neurological features similar to Wilson's <0.26 g/l, and sera from patients with Wilson's disease. disease were subjected to 8% SDS-PAGE as described previously.11 Proteins from the gel were transferred Measurement of caeruloplasmin oxidase to a nylon membrane using a semi-dry blotter activity in serum (Biorad) for 90 min at a constant current of 1 mA/cm2. The blot was blocked in 5% milk solution containing Caeruloplasmin oxidase activity is absent in Wilson's 50 mM Tris/150 mM NaCl, pH 7.4, and 0.02% disease sera compared to sera from normal control sodium azide for 2 h, and incubated for 3 h with subjects and all other disease categories (Table 3) . sheep anti-human caeruloplasmin conjugated to This confirms the non-functional activity of this horseradish peroxidase. The blot was washed several protein in Wilson's disease and can usefully be a times in Tris/NaCl buffer, and caeruloplasmin was complementary test in confirming the diagnosis of detected using the chemiluminescent method (ECL)
Wilson's disease. as described by Amersham.
Caeruloplasmin oxidase assay Discussion
Although all patients with Wilson's disease have Caeruloplasmin oxidase activity was measured as described previously.12 Serum samples containing liver damage, only about 40% of them first present with liver disease,3,13 which may need to be distingu-2 mg protein were added to a plastic cuvette containing 0.6 ml 0.1M sodium acetate buffer pH 6.0, ished from chronic active hepatitis.3,4 There are other More specific tests for detecting caeruloplasmin have not been forthcoming, with the exception of a enzyme-linked immunosorbent assay using two antihuman caeruloplasmin monoclonal antibodies.29 This technique was described for assay of holocaeruloplasmin in blood and may be useful in screening neonatal blood for Wilson's disease, but it is both time-consuming and expensive.
In this study, we have shown that caeruloplasmin detected by Western blotting may be used to distin- activity of the protein which is defective in Wilson's disease, and in conjunction with Western blot analysis described in this study, can also be used to disease, as it is in Menke's disease (genetic copper confirm Wilson's disease. This offers a potentially deficiency) until the later stages of the disease which simple, rapid and economical test which could be is unlike other causes of liver disease, but the provided by any laboratory, using only 3-10 ml of concentrations are variable and not diagnostic. serum to identify caeruloplasmin isoforms. Such a Similarly monitoring of increased urinary copper rapid test involving small amounts of serum would excretion can be helpful in the diagnosis, but may be very appropriate for use in children (because of also be increased in chronic active hepatitis due to the small quantities of blood samples available), other causes, and is more useful as a marker of where it could lead to earlier diagnosis and treatment successful treatment indicating copper depletion. In of the disease. It would be possible to develop normal subjects, urinary copper excretion is less than 70 mg/l (24 h) whilst in Wilson's disease this may be this test further using a dried-blood-spot method. intracellular copper is compartmentalized into three main components. A cytosolic component for incorp-
